Posted Sep. 22, 2012 at 6:23 a.m.
Research Triangle Park, N.C. — Drugmakers may push to boost U.S. government spending on prescription drugs even as the U.S. Congress seeks to reduce health-care spending, according to internal documents from the industry's top lobbying group.Copyright 2013 Bloomberg. All rights reserved.
GSK, drug makers may push for expanded US payments
Post a comment
Print this blog postE-mail blog post
Share
Research Triangle Park, N.C. — Drugmakers may push to boost U.S. government spending on prescription drugs even as the U.S. Congress seeks to reduce health-care spending, according to internal documents from the industry's top lobbying group.Copyright 2013 Bloomberg. All rights reserved.
Please Log In to add a comment.
Best of TechWire Insider
The Skinny
Raleigh-based PRA International eyes public offering
Will lightning strike again for veteran entrepreneur Brian Handly at StepLeader?
Raleigh app developer StepLeader lands $4.4M in first fund raiser
IBM opens Linux center in China, says it will work with Red Hat
Red-hot Raleigh startup WedPics hauls in $1.1M in funding
New Triangle venture capital firm slowly emerging from shadows
Titans of tech seek to excite UNC, Duke grads about a future beyond themselves
Triangle politician tries to accelerate crowdfunding; bill passes first hurdle
ChannelAdvisor seeks $80M, sets share target price for IPO
IT job openings 28% below 2012 numbers, report shows















